Eiji Kobayashi, Yusuke Kamihara, Miho Arai, Akinori Wada, Shohei Kikuchi, Ryo Hatano, Noriaki Iwao, Takeshi Susukida, Tatsuhiko Ozawa, Yuichi Adachi, et al. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells. 2023. 12. 16. 2059-2059
Shohei Kikuchi, Akinori Wada, Yusuke Kamihara, Kosuke Okazaki, Paras Jawaid, Mati Ur Rehman, Eiji Kobayashi, Takeshi Susukida, Tomoki Minemura, Yoshimi Nabe, et al. DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies. Cells. 2023. 12. 7
My Thi Viet Ha, Hiroshi Hamana, Kiyomi Shitaoka, Abdul Hayee, Eiji Kobayashi, Toshiaki Yoshikawa, Tetsuya Nakatsura, Reiko Saikawa, Eri Sato, Mitsujiro Osawa, et al. Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers. Cancer science. 2023
Eiji Kobayashi, Tatsuhiko Ozawa, Hiroshi Hamana, Atsushi Muraguchi, Hiroyuki Kishi. Gene modified NK cell line as a powerful tool for evaluation of cloned TCRs for TCR-T cell therapy. Cellular Immunology. 2023. 383. 104656-104656
Tomoko Nakamura, Eiji Kobayashi, Hiroshi Hamana, Yoshihiro Hayakawa, Atsushi Muraguchi, Atsushi Hayashi, Tatsuhiko Ozawa, Hiroyuki Kishi. Evaluation of chimeric antigen receptor of humanized rabbit-derived T cell receptor-like antibody. Cancer science. 2022